These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 38280)

  • 1. Biological characteristics of peptidoglycans of group A streptococcus and some other bacterial species. II. Immunological mechanisms involved in thrombocytolysis.
    Rýc M; Rotta J
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(4):435-41. PubMed ID: 38280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thrombocytolytic activity of bacterial peptidoglycans.
    Rýc M; Rotta J
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):265-72. PubMed ID: 126559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characteristics of peptidoglycans of group A streptococcus and some other bacterial species. I. Tolerance and effect of antibody in fever response, and heart damaging effect in rabbits.
    Rotta J; Bednár B; Rýc M
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(4):433-40. PubMed ID: 25304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin-like properties of the peptidoglycan.
    Rotta J
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):230-44. PubMed ID: 126556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of peptidoglycans with anti-IgGs and with complement.
    Bokisch VA
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):320-30. PubMed ID: 126565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of synthetic subunits of streptococcus peptidoglycan. I. Pyrogenic and thrombocytolytic activity.
    Rotta J; Rýc M; Masek K; Zaoral M
    Exp Cell Biol; 1979; 47(4):258-68. PubMed ID: 381070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration inhibition of peritoneal macrophages by peptidoglycan.
    Bültmann B; Heymer B; Schleifer KH; Seidl HP; Haferkamp O
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):289-94. PubMed ID: 126562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Skin reactions to isolated bacterial cell wall components, bacterial peptidoglycan in particular].
    von Mayenburg J; Heymer B; Düngemann H; Schleifer KH; Seidl HP; Galle J; Neiss A; Borelli S
    Z Hautkr; 1980 Jun; 55(11):710-33. PubMed ID: 7415356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies.
    Verbrugh HA; van Dijk WC; Peters R; van Erne ME; Daha MR; Peterson PK; Verhoef J
    J Immunol; 1980 Mar; 124(3):1167-73. PubMed ID: 7358981
    [No Abstract]   [Full Text] [Related]  

  • 10. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci.
    Langone JJ
    Adv Immunol; 1982; 32():157-252. PubMed ID: 7051784
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological activity of the peptidoglycan.
    Krause RM
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):136-50. PubMed ID: 52236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological properties of the peptidoglycan.
    Heymer B
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):245-57. PubMed ID: 126557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic responses induced by peptidoglycans with or without in vivo antitumor activity.
    Goguel AF; Payelle B; Lespinats G; Nauciel C
    J Natl Cancer Inst; 1983 Aug; 71(2):325-30. PubMed ID: 6603557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus.
    Musher DM; Verbrugh HA; Verhoef J
    J Immunol; 1981 Jul; 127(1):84-8. PubMed ID: 7240751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil chemotactic activity of peptidoglycan. A comparison between Staphylococcus aureus and Staphylococcus epidermidis.
    Riber U; Espersen F; Wilkinson BJ; Kharazmi A
    APMIS; 1990 Oct; 98(10):881-6. PubMed ID: 2245008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the alternate complement pathway by peptidoglycan of Actinomyces viscosus, a potentially pathogenic oral bacterium.
    Baker JJ; Billy SA
    Arch Oral Biol; 1983; 28(11):1073-5. PubMed ID: 6362630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of one particular subset of natural killer cells by peptidoglycans extracted from gram-positive bacteria.
    Goguel AF; Payelle B; Quan PC; Lespinats G
    J Natl Cancer Inst; 1984 Sep; 73(3):697-703. PubMed ID: 6590915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to various bacterial cell wall peptidoglycans in human and rabbit sera.
    Wergeland HI; Endresen C
    J Clin Microbiol; 1987 Mar; 25(3):540-5. PubMed ID: 2437150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae].
    Andreoni O
    Minerva Med; 1983 Mar; 74(12):619-24. PubMed ID: 6339995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibodies to bacterial cell wall peptidoglycan in human sera.
    Heymer B; Schleifer KH; Read S; Zabriskie JB; Krause RM
    J Immunol; 1976 Jul; 117(1):23-6. PubMed ID: 778264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.